Grace Therapeutics, Inc. (GRCE) NASDAQ
4.42
+0.22(+5.24%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.42
+0.22(+5.24%)
Currency In USD
| Market Cap | 27.56M |
| Enterprise Value | 5.43M |
| P/E Ratio | -10.94 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.15 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -5.64 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.1 |
| Return On Equity | -0.11 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -16.67M |
| Net Income | -9.57M |
| Diluted EPS | -0.79 |
| Total Cash | 18.67M |
| Total Cash/Share | 1.1 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 14.96 |
| Book Value Per Share | 3.83 |
| 52-Week Change | 93.01 |
| 52-Week High | 4.65 |
| 52-Week Low | 1.75 |
| Moving Average 50 Days | 3.78 |
| Moving Average 200 Days | 3.28 |
| Average Volume | 176,500 |
| Shares Outstanding | 14.13M |
| % Held by Institutions | 25.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | July 10, 2023 |